SIGN UPLog In

General

Financials

Activity

Recent News

Last deal

$32M

Amount

Venture - Series Unknown

Stage

30.12.2022

Date

1

all rounds

$32M

Total amount

date founded

Financing round

General

About Company
Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2021

Number of employees

11-50

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Aliada Therapeutics utilizes a versatile platform to develop CNS drugs, including monoclonal antibodies, enzymes, oligonucleotides, peptides, and other proteins. Their customizable delivery technology targets the blood-brain barrier, enabling effective treatment of CNS diseases. The company is focused on progressing specific CNS target antibody binders through preclinical evaluation to provide medical professionals with innovative therapies for CNS diseases. Founded in 2021 and headquartered in Boston, Massachusetts, Aliada Therapeutics is at the forefront of redefining CNS drug development.
Contacts

location

Boston, MA, USA

Contact Email

Website URL

https://www.aliadatx.com/

Social url

Similar Companies
1000
Prazer Therapeutics
Prazer TherapeuticsPrazer Therapeutics is a biotech company that develops innovative therapeutics for refractory diseases.
Prazer Therapeutics

Prazer Therapeutics

Prazer Therapeutics is a biotech company that develops innovative therapeutics for refractory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Seoul, South Korea

total rounds

1
Amagma Therapeutics
Amagma TherapeuticsAmagma Therapeutics develops antibody therapies for inflammatory diseases.
Amagma Therapeutics

Amagma Therapeutics

Amagma Therapeutics develops antibody therapies for inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Waltham, MA, USA

total rounds

3

total raised

$18.65M
Amyl Therapeutics
Amyl TherapeuticsAmyl Therapeutics is a preclinical-stage biotechnology platform developing therapies to treat all forms of amyloidosis.
Amyl Therapeutics

Amyl Therapeutics

Amyl Therapeutics is a preclinical-stage biotechnology platform developing therapies to treat all forms of amyloidosis.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Liège, Belgium

total rounds

4

total raised

$30.34M
VBL THERAPEUTICS
VBL THERAPEUTICSVBL Therapeutics is a clinical stage biotech company that develops innovative treatments for cancer and immune-inflammatory diseases.
VBL THERAPEUTICS

VBL THERAPEUTICS

VBL Therapeutics is a clinical stage biotech company that develops innovative treatments for cancer and immune-inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Or Yehuda, Israel

total rounds

6

total raised

$58.72M

Financials

Funding Rounds
1
1

Number of Funding Rounds

$32M

Money Raised

Their latest funding was raised on 30.12.2022. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
30.12.2022
Venture - Series Unknown
—
$32M
—
Co-Investors

Activity

Recent News
0